Contact Us


    Your Name (required)

    Your Email (required)

    Your Phone (required)

    Subject

    Interested In... (required)

    Your Message

    Pharmaceutical 3PL Compliance

    Logistics Services Providers Assure Immediate Order Fulfillment for Manufacturers With Approved PLAIR Requests

    Pre-Launch Activities Must Be Completed Prior To Initial Shipment Pharmaceutical manufacturers rely on Logistics Services Providers including WDSrx to provide healthcare supply chain solutions that assure medications reach their destinations when promised. Government regulatory authorities including the Federal Food and Drug Administration must approve all medications before they are able to be commercially available. Under special circumstances, unapproved drugs may be prepared for product laun...

    Validation Documentation Completed for Regulatory Compliance

    Upgrades to hardware and software systems at WDSrx increase efficiency and capabilities for clients. Each point of access connecting to WDSrx internal systems must be validated for Installation Qualification (IQ), Operational Qualification (OQ) and Performance Qualification (PQ) to assure pharmaceutical 3PL compliance with 21CFR210/211 guidelines. Validation projects are managed by the WDSrx Regulatory Compliance team. Proper validation documents are made available when requested for client audi...

    WDSrx Monthly News Update August 2017

    WDSrx gets published on DC Velocity, sponsors an HDA Serialization Survey, attends NACDS this month and welcomes a new member of our business development team. Read our monthly update for details.  For further information contact WDSrx at info@wdsrx.com or (561) 998-3885....

    WDSrx IMPLEMENTS DSCSA PHARMACEUTICAL 3PL COMPLIANCE PRIOR TO FDA DEADLINE

    Pharmaceutical 3PL Provider Selects ROC IT, TraceLink and Optel Vision For DSCSA Implementation Boca Raton, FL (August 22, 2016)  – WDSrx, a pharmaceutical 3PL provider based in Boca Raton, FL selected ROC IT, TraceLink and Optel Vision to assist with the transition to comply with requirements in the Drug Supply Chain Security Act (DSCSA).  The law requires all companies within the pharmaceutical supply chain to develop an electronic system designed to increase patient safety by minimizi...

    Are any Controlled Substances (CII) included in your return? If so, please press "Yes" and complete the DEA 222 Request Form. You can also contact Jason Solomon at jsolomon@wdsrx.com or (561) 998-3885 x316.